Atara Biotherapeutics (ATRA) 3.64M Offering Prices at $18/Share

February 12, 2015 8:14 AM EST Send to a Friend
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a biopharmaceutical development company with a focus on innovative therapies for patients with debilitating diseases ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login